DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Abroad (travel likely)RecruitingPHASE4
Conditions
Type2diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Kyung Hee University Hospital at Gangdong, Seoul, South Korea
Contact: Study coordinator (Kyung Hee University Hospital at Gangdong) · cri@khnmc.or.kr · 82+2-440-7000